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Abstract
Between June 2007 and January 2008, 26 Klebsiella pneumoniae iso-
lates carrying blaDHA-1 on an IncL/M plasmid were obtained from
clinical samples at Granollers Hospital, Barcelona, Spain. Three of
the isolates also carried a blaCTX-M-15 gene. The 26 isolates showed
11 pulsed-ﬁeld gel electrophoresis (PFGE) patterns. Multilocus
sequence typing showed that PFGE patterns A, B and C belonged
to sequence type (ST)17, D to ST13, E to ST427, F and G to
ST416, H to ST37, I to ST440, J to ST326, and K to ST428. Results
demonstrated the effectiveness of the infection control pro-
gramme in place at the centre. This study reports the ﬁrst charac-
terization of STs for blaDHA-1-producing K. pneumoniae isolates.
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These results were partially presented at the 2009 Annual Meeting of
the Sociedad Espan˜ola de Enfermedades Infecciosas y Microbiologı´a
Clı´nica in Sevilla, Spain (Epidemiologı´a de las cepas de Klebsiella pneu-
moniae productoras de cefamicinasa en un hospital comarcal), and at
the 20th European Congress of Clinical Microbiology and Infectious
Diseases, 2010, Vienna, Austria (Multilocus sequence typing of DHA-
1-producing Klebsiella pneumoniae isolates in a Spanish hospital).
Gram-negative bacilli expressing chromosomal AmpC
b-lactamases could acquire resistance to cephalosporins by
hyperproduction of their b-lactamase [1]. Moreover, since
1989, these AmpC genes or genes derived from AmpC
genes have been detected on plasmids and in species that do
not naturally produce AmpC enzymes, such as Klebsiella
oxytoca, Salmonella spp. and Proteus mirabilis, and especially
Klebsiella pneumoniae isolates [1,2]. The plasmid-mediated
AmpC b-lactamases described to date can be grouped in
families: ACC, CMY, DHA, FOX, MIR, ACT or MOX.
The present study aimed to document nosocomial infec-
tions caused by different clusters of AmpC-producing
K. pneumoniae isolates between June 2007 and January 2008
at Granollers Hospital (Barcelona, Spain). This is a medical
referral centre with 297 acute-care beds, 22 intensive-care
beds and an average of 17 161 admissions per year. In June
2007, the Microbiology and Infectious Diseases Department
reported the detection of ﬁve nosocomial K. pneumoniae cef-
otaxime-resistant and cefoxitin-resistant isolates. The infec-
tion control team immediately began to investigate a possible
outbreak.
Between June 2007 and January 2008, a total of 2885
enterobacterial isolates were obtained from 2459 patients
consecutively admitted to Granollers Hospital. Of these, 26
K. pneumoniae isolates (corresponding to 26 patients)
showed resistance, by the disk diffusion method, to amoxy-
cillin–clavulanic acid, cefoxitin, cefotaxime, ceftazidime and
aztreonam, and were susceptible to carbapenem according
to CLSI breakpoints [3]. This resistance pattern suggested
the production of an AmpC enzyme. Additionally, three of
these isolates showed synergy between amoxycillin–clavulanic
acid and cefotaxime on Mueller–Hinton agar, suggesting
production of extended-spectrum b-lactamases (ESBLs).
The 26 isolates were obtained from 17 male and nine
female patients with mean ages of 60 and 75 years, respec-
tively. One of the patients was transferred from another
hospital, three patients had community-acquired infection or
colonization with no relation to our hospital, and the other
23 patients were inpatients or patients related to healthcare
facilities. Urine was the most frequent source of K. pneumo-
niae isolation (17 isolates, 62.9%) (Table 1). Thirty-ﬁve per -
cent of patients had previously been treated with
amoxycillin–clavulanic and 11.5% with cephalosporins. By the
time the microbiological result was known, ﬁve patients had
already started inadequate treatment with b-lactams. Never-
theless, four developed favourably without change in the
treatment. The ﬁfth patient died before the treatment was
changed.
b-Lactamase genes were characterized by PCR and
sequenced as previously described [4]. The results revealed
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that blaDHA-1 was present in all 26 isolates, and three of
them also had blaCTX-M-15. Resistance to other antibiotic
agents is shown in Table 1. DHA-1-producing isolates were,
in some cases, resistant only to nalidixic acid, whereas CTX-
M-15-producing isolates were resistant to aminoglycosides,
co-trimoxazole, tetracycline and quinolones. The presence
of plasmid-mediated quinolone resistance (qnrA, qnrB, qnrS
and aac(6¢)-Ib-cr) was investigated by PCR [5]. Twenty-ﬁve of
the isolates contained qnrB, and the three ESBL-producing
isolates also carried aac(6¢)-Ib-cr. Associations between
blaDHA-1 and qnrB, between aac(6¢)-Ib-cr and blaCTX-M-15
and between blaDHA-1 and blaCTX-M-15 have been reported
previously [5–7].
The clonal relationships between K. pneumoniae clinical
isolates were analysed by comparing pulsed-ﬁeld gel electro-
phoresis (PFGE) proﬁles of genomic DNA, as previously
described [8]. A total of 11 major patterns were obtained
among the 26 K. pneumoniae isolates (Fig. 1); ﬁve of them
were clusters with seven isolates (A), four isolates (B) or
three isolates (C, E and J). The three DHA-1-producing and
CTX-M-15-producing isolates belonged to the J pattern.
Multilocus sequence typing was applied according to the
Institute Pasteur scheme for K. pneumoniae [9]. Only one iso-
late for each PFGE pattern was selected for multilocus
sequence typing. The 11 PFGE patterns corresponded to dif-
ferent K. pneumoniae sequence types (STs): PFGE A, B and C
belonged to ST17, D to ST13, E to ST427, F and G to
ST416, H to ST37, I to ST440, J to ST326, and K to ST428.
ST13 has been previously found in Seoul and Madrid, associ-
ated with CTX-M-14 and CTX-M-15, respectively [9–11]
(Valverde et al., 19th ECCMID, 2009, P1195), ST17 in Cadiz,
associated with CTX-M-15, in Freiburg and in Seoul (ESBL
association not shown) [9,10,12], ST37 in Madrid, associated
with SHV-12, in Rome, in Germany and in Seoul (ESBL asso-
ciation not shown) [9–11,13] (Valverde et al., 19th ECCMID,
2009, P1195), and ST326 in two hospitals in Barcelona, asso-
ciated with CTX-M-15 [13]. By eBURST (http://eburst.mlst.
net), all STs except ST17 and ST37 were considered to be
singletons. ST17 belongs to the ST17 complex, which con-
tains four single-locus variants and six double-locus variants,
and ST37 to the ST37 complex, with only two single-locus
variants. ST416, ST427, ST428 and ST440 are described here
for the ﬁrst time.
We selected one isolate from each clone (A, B, C, E and J)
to obtain transconjugants and characterize plasmids. Trans-
conjugants were obtained by ﬁlter matting experiments, as
previously described [4]. The incompatibility group of plas-
mids carrying bla was determined by PCR, PFGE with S1
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FIG. 1. Dendogram, pulsed-ﬁeld gel electro-
phoresis (PFGE) patterns and their correspon-
dence with multilocus sequence typing proﬁles
of the 26 Klebsiella pneumoniae strains produc-
ing DHA-1. Similarity was calculated by using
Dice coefﬁcients with a position tolerance of
1% (Fingerprinting II Software; Bio-Rad). The
cut-off level for identity was set at 90%. ST,
sequence type.
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nuclease and Southern blot hybridization methods, as
described previously [14,15]. The blaDHA-1 gene was located
in a plasmid of 180 kb belonging to the L/M incompatibility
group in all isolates except for one with a plasmid of 120 kb.
The blaCTX-M-15 gene was detected in the same L/M plasmid
that contained blaDHA-1. Moreover, this plasmid also con-
tained an FII replicon. The nucleotide sequence correspond-
ing to the FII replicon obtained by PCR showed more than
98% identity with the IncFII replicon of plasmids pKPN3,
pKPN4 and pKpQIL from K. pneumoniae (GenBank accession
numbers: CP000648, CP000649 and GU595196).
In 2000, FOX-4 was the ﬁrst plasmid-mediated AmpC
b-lactamase to be detected in Spain (in the Canary Islands)
[16]. Since then, the prevalence of AmpC-producing entero-
bacteria has increased [4,16–19]. However, detection of
these enzymes is difﬁcult, and they could be undetected or
misidentiﬁed as ESBLs [1,20].
Few outbreaks of DHA-1-carrying K. pneumoniae have
been described in the literature [1,21,22]. One of these
included the presence of isolates co-producing AmpC and
ESBLs [22]. In the present article, we describe the associa-
tion of blaDHA-1 and blaCTX-M-15 in the same plasmid of the
L/M-FII incompatibility group. The isolate belonged to ST326.
An ST326 isolate carrying only a CTX-M-15 ESBL had
previously been found in two hospitals in Barcelona[13].
Moreover, the most predominant plasmid-mediated AmpC
b-lactamase observed since 2005 in K. pneumoniae in Barce-
lona is DHA-1 [17].
The distinctive characteristic of the present study is the
multiclonal aspect of the supposed outbreak, which sub-
sided in a short period of time. Our hypothesis is that
community clones entered the hospital and spread by
cross-infection, because three patients with community-
acquired infections with no previous relation to our
hospital were clonally related to isolates of three different
nosocomial clusters.
The small number of patients per cluster was probably
attributable to the infection control programme in place in
the centre. This programme includes contact precautions for
all K. pneumoniae ESBL-positive patients and their environ-
ments, and an internal combined hand hygiene and antibiotic
policy. The fact that all 26 patients were isolated in single
rooms may also have played a role.
From this study, we can conclude that an increase in the
incidence of a resistance mechanism does not always imply
an outbreak. This appears to be true even when a low-
prevalence resistance phenotype is observed. Accordingly, it
is important to stress the relevance of the community as a
reservoir of antimicrobial-resistant K. pneumoniae to explain
this non-clonally related diffusion.
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Abstract
Klebsiella pneumoniae Kp1 carrying a novel complex class 1 integ-
ron was isolated from an inanimate surface of a female ward
sanitary facility in the Hospital Infante D. Pedro, Aveiro, central
Portugal. The integron consists of two variable regions (VRs);
VR1 was previously described in Escherichia coli and Vibrio chole-
rae, and VR2 contains an In37-like structure and is located
downstream of an ISCR1 element. The integron was found on a
plasmid of 225 kb. The qnrB10 gene, although present, is not
associated with the complex class 1 integron.
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Klebsiellae are widespread in the environment and in the
intestinal ﬂora of humans and other mammals. Klebsiella pneu-
moniae is an important opportunistic pathogen causing uri-
nary tract and intra-abdominal infections, neonatal meningitis
and pneumonia in immunocompromised patients [1].
The intensive use of broad-spectrum antibiotics in hospi-
talized patients led to the development of multidrug-resistant
(MDR) strains. In K. pneumoniae, resistance is associated with
the production of b-lactamase enzymes, mainly extended-
spectrum b-lactamases [2]. However, more recently, metal-
lo-b-lactamases have also been described [3].
K. pneumoniae strains carrying complex class 1 integrons
are becoming more common. Usually, within the second var-
iable region (VR2), only one or two genes conferring resis-
tance to b-lactamases, ﬂuoroquinolones, aminoglycosides,
chloramphenicol or trimethoprim are found [4–7]. Thus, the
use of antibiotics that are commonly used to treat infections
caused by Klebsiella MDR strains, such as cephalosporins,
b-lactamase-stable penicillins and aminoglycosides, can be
compromised [8].
Herein, we report and characterize a novel complex
class 1 integron found in a K. pneumoniae isolate collected
from an inanimate surface within the Hospital Infante
D. Pedro, Aveiro, Central Portugal.
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